SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006821
Filing Date
2018-08-09
Accepted
2018-08-09 06:30:11
Documents
121
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20180630x10q.htm 10-Q 2513599
2 EX-10.1 bgne-20180630ex1012a92b2.htm EX-10.1 339420
3 EX-10.5 bgne-20180630ex105abd65e.htm EX-10.5 38329
4 EX-10.7 bgne-20180630ex107a9f0fd.htm EX-10.7 207755
5 EX-10.8 bgne-20180630ex108bf33ac.htm EX-10.8 115763
6 EX-31.1 bgne-20180630ex311d9cfb0.htm EX-31.1 21785
7 EX-31.2 bgne-20180630ex312c040de.htm EX-31.2 21199
8 EX-32.1 bgne-20180630ex3213a301a.htm EX-32.1 13583
  Complete submission text file 0001558370-18-006821.txt   10185022

Data Files

Seq Description Document Type Size
9 EX-101.INS bgne-20180630.xml EX-101.INS 1954944
10 EX-101.SCH bgne-20180630.xsd EX-101.SCH 85491
11 EX-101.CAL bgne-20180630_cal.xml EX-101.CAL 99646
12 EX-101.DEF bgne-20180630_def.xml EX-101.DEF 259861
13 EX-101.LAB bgne-20180630_lab.xml EX-101.LAB 585949
14 EX-101.PRE bgne-20180630_pre.xml EX-101.PRE 526425
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 181003101
SIC: 2834 Pharmaceutical Preparations